Empowering fertility patients to actively engage in the fertilisation stages of their embryos with Anevivo™

The AneVivo device is a porous capsule that enables in Vivo Development to take place in the natural physiological environment of the maternal womb instead of the laboratory incubator

device cover

A step closer to nature with the CE Marked Medical Device AneVivo

Empowering fertility patients to actively engage in the fertilisation stages of their embryos

Carry

Carry injected or inseminated oocytes and gametes into the uterine cavity for fertilization and very early development.

Maintain

Maintain the embryos in the desired intra-uterine position whilst in the womb.

Enable

Allow safe and easy placement / retrieval of all embryos in / from the uterus to ensure a seamless transition with all the other stage of the treatment (i.e. morphological evaluation, if needed / allowed genetic diagnostics, …).

Permit

Permit bidirectional passage of fluid between the embryo and the mother providing the full range of nutrients and natural components needed for the development and mother-embryo interactions.

Technological Innovation and Precision

The Anecova cell encapsulation technology was developed in collaboration with one of the world’s few specialized laboratories with high-level expertise in the subject at the EPFL Lausanne in Switzerland.

tech Innovation
device

To produce the AneVivo device, precision manufacturing techniques were borrowed from the watch-making and microprocessor industries.

The device is produced with exceptional craftsmanship and assembled by hand in state-of-the-art facilities in Switzerland.

The AneVivo Medical Device is:

  • Ce marked
  • Fully tested for embryo development
  • Comfortable for the patient
  • Translucent under direct vision, visible by ultrasound
  • Easily manipulated by both the embryologist and the gynecologist
cell

Creditation

The AneVivo device is approved by the local Competent Authorities for its use in clinical practice for the treatment of infertility in UK (HFEA), Spain (AEMPS, Consejerias de sanidad), Denmark (Sundhedsstyrelsen), Czech Republic (MZCR) and Poland (URPL). Switzerland and other countries are in the pipeline.

European Clinical Partners

Partner logo
Partner logo
Partner logo